The Latest Breaking News from Omicron

AstraZeneca In-Licenses New Suite Of COVID-19 Antibody Candidate(s)

AstraZeneca plc (NASDAQ:AZN) moved to bolster its COVID-19 portfolio of antibodies with a $157 million licensing deal for experimental therapies developed by newly-launched UK-based biotech, RQ Biotechnology Ltd. In addition to the initial sum, AstraZeneca will pay possible royalty payments as part of the exclusive license to develop pre-clinical COVID antibodies engineered by RQ…

Benzinga · May 17, 2022

FDA May Authorize Pfizer-BioNTech's COVID-19 Booster For 5-11 Year Kids Soon: NYT

The FDA is expected to authorize a booster shot of Pfizer Inc (NYSE:PFE) / BioNTech SE's (NASDAQ:BNTX) COVID-19 vaccine for children aged 5 to 11 probably by today, the New York Times reported, citing people familiar with the matter. The companies submitted an application to the FDA for authorization last month. They have cited data from…

Benzinga · May 17, 2022

Factbox-COVID-hit Chinese cities seek exit from painful lockdown

Plans by COVID-hit Chinese cities to exit or avoid lockdown are more fraught and uncertain than ever as the pursuit of zero cases grows more prolonged, taxing and complex, with the highly infectious Omicron variant demanding quicker and tougher steps.

Reuters · May 17, 2022

Got COVID again? Your symptoms may be milder, but this won’t always be the case

How sick will you get the second time? While COVID symptoms are likely to be less severe, in some cases they can be worse. Here's what we know so far.

The New Daily · May 16, 2022

Got COVID again? Your symptoms may be milder, but this won't always be the case

So, you’re starting to feel unwell. Your throat hurts, your head aches, you feel tired and you’ve developed a cough.

The Conversation · May 16, 2022

Ryanair FY22 Loss Narrows, Expects To Return To Profitability In FY23

Ryanair Holdings plc (NASDAQ:RYAAY) reported FY22 revenue growth of 193% year-over-year to €4.8 billion. The company reported an FY22 net loss of €(355) million, compared to a €(1.05) billion loss a year ago. Scheduled revenues were up 156% Y/Y, reflecting a rise in traffic from 27.5 million customers to 97.1 million. Ancillary…

Benzinga · May 16, 2022

With COVID cases rising, how close is California to new mask rules, restrictions?

SAN FRANCISCO — With coronavirus cases continuing to rise in some parts of California, the big question is when some local governments may decide a wave is big enough to intervene with new rules.

Los Angeles Times · May 16, 2022

Omicron symptoms: Nine signs you might be infected - even if fully vaccinated

A new Norwegian study has found the Omicron symptoms you should watch out for - including unusual signs that you may not associate with having contracted Covid-19

Daily Mirror · May 16, 2022

Just how accurate are rapid antigen tests? Two testing experts explain the latest data

As of May 2022, the U.S. is experiencing another uptick in the number of COVID-19 cases. High rates of infection in Europe and Asia, along with the continued emergence of new sub-variants, such as omicron BA.4 and BA.5, raise concerns that another surge could be on the way.

The Conversation · May 16, 2022

We need a definitive exit from our Covid-19 pandemic. Here’s the roadmap

Nasal or oral coronavirus vaccines, more and better drugs, and a variant-proof vaccine could catalyze a clear way out

The Guardian - US · May 16, 2022